Innovative Biotherapies, Inc.
Ann Arbor, MI · Medtech · Private
Selective Cytopheretic Device (SCD), an extracorporeal blood-contacting medical device that selectively removes activated white blood cells through immunomodulatory fiber interactions to treat inflamm
- Grants
- $8.7M
- 11 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · L-MOD Therapy: Leukocyte Immunomodulation during Cardiopulmonary Bypass | $588,700 | |
| Federal grant | Department of Health and Human Services · Phase I · Fiber design and assessment for development of a novel biomimetic medical device | $323,816 | |
| Federal grant | Department of Health and Human Services · Phase I · Biomimetic Membrane Device for Therapeutic Application in Chronic Heart Failure | $655,205 | |
| Federal grant | Department of Health and Human Services · Phase II · Fiber design and assessment for development of a novel biomimetic medical device | $1,880,650 | |
| Federal grant | Department of Health and Human Services · Phase II · Fiber design and assessment for development of a novel biomimetic medical device | $763,998 | |
| Federal grant | Department of Health and Human Services · Phase II · Fiber design and assessment for development of a novel biomimetic medical device | $553,299 | |
| Federal grant | Department of Health and Human Services · Phase I · SCD-PICC Therapy for Respiratory Insufficiency associated with COVID-19 in non-ICU settings | $325,257 | |
| Federal grant | Department of Health and Human Services · Phase I · SCD-PICC Therapy for Respiratory Insufficiency associated with COVID-19 in non-ICU settings | $6,500 | |
| Federal grant | Department of Health and Human Services · Phase II · Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients | $1,314,026 | |
| Federal grant | Department of Health and Human Services · Phase II · Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients | $1,513,922 | |
| Federal grant | Department of Health and Human Services · Phase II · Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients | $797,411 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 788 | Operational Techologies Corporation | — | — |
| 789 | SUBTLE TECHNOLOGY LLC | — | — |
| 790 | Nuclein, LLC | — | $2.5M |
| 791 | Innovative Biotherapies, Inc. | — | — |
| 792 | SAFETYSPECT, INC. | — | $106K |
| 793 | KoKo Medical, Inc. | — | $27M |
| 794 | AttoDx, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- An Extracorporeal Cell-based Therapeutic Device And Delivery Systemapplication
- Selective Cytopheresis Devices And Related Methods Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.